News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|September 2, 2016

Pancreatic NETs: What to Ask Your Oncologist

Episodes in this series

EP. 1 What Are Neuroendocrine Tumors?

EP. 1 What Are Neuroendocrine Tumors?

EP. 2 Pancreatic NETs: Michael's Story

EP. 2 Pancreatic NETs: Michael's Story

EP. 3 A Surgery Story: Pancreatic NETs

EP. 3 A Surgery Story: Pancreatic NETs

EP. 4 Why You Need an Expert in NETS

EP. 4 Why You Need an Expert in NETS

EP. 5 Living with Carcinoid Tumors

EP. 5 Living with Carcinoid Tumors

EP. 6 Brenda's Carcinoid Tumor Diagnosis

EP. 6 Brenda's Carcinoid Tumor Diagnosis

EP. 7 Why Carcinoid Tumors Might Be Missed

EP. 7 Why Carcinoid Tumors Might Be Missed

EP. 8 What a Carcinoid Cancer Diagnosis Means

EP. 8 What a Carcinoid Cancer Diagnosis Means

EP. 9 NETs: The First Steps to Treatment

EP. 9 NETs: The First Steps to Treatment

EP. 10 About The Carcinoid Cancer Foundation

EP. 10 About The Carcinoid Cancer Foundation

EP. 11 Finding Answers to Your First Questions

EP. 11 Finding Answers to Your First Questions

EP. 12 Reasons for Starting Treatment of NETs

EP. 12 Reasons for Starting Treatment of NETs

EP. 13 Pancreatic NETs: What to Ask Your Oncologist

EP. 13 Pancreatic NETs: What to Ask Your Oncologist

EP. 14 Treating Pancreatic NETs

EP. 14 Treating Pancreatic NETs

EP. 15 Carcinoid Tumors: What to Ask Your Oncologist

EP. 15 Carcinoid Tumors: What to Ask Your Oncologist

EP. 16 Approach to Treating Carcinoid Tumors

EP. 16 Approach to Treating Carcinoid Tumors

EP. 17 Patient Treatment Experiences

EP. 17 Patient Treatment Experiences

EP. 18 NETs: A Personalized Approach

EP. 18 NETs: A Personalized Approach

EP. 19 The Need for Support

EP. 19 The Need for Support

EP. 20 Affording the Best Care

EP. 20 Affording the Best Care

Newsletter

Stay up to date on cancer updates, research and education

Related Content

FDA

FDA Grants Breakthrough Designation to Zovegalisib for Breast Cancer

February 4th 2026

breast cancer

FDA Grants Priority Review to Datroway for Metastatic Triple-Negative Breast Cancer

February 3rd 2026

Dr. Kathie-Ann Joseph

Breaking Down Surgical Advancements for Those With Breast Cancer

ByDr. Kathie-Ann Joseph

February 2nd 2026

A real-world study found Erleada reduced the risk of death compared with darolutamide in patients with metastatic castration-sensitive prostate cancer: © stock.adobe.com.

Erleada Shows Survival Advantage in Real-World Study of Metastatic Prostate Cancer

February 2nd 2026

breast cancer

CD47 Protein May Predict Evorpacept Success in Metastatic Breast Cancer

February 2nd 2026

Trending on CURE

Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us

FDA Grants Priority Review to Datroway for Metastatic Triple-Negative Breast Cancer

Why World Cancer Day Matters to Patients and Survivors

U.S. Soccer Legend Kasey Keller Reveals Lymphoma Journey

What is the Goal of Multiple Myeloma Treatment?